Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Anti-craving effects of environmental enrichment
International Journal of Neuropsychopharmacology, 09/24/09
Thiel KJ et al. – The findings suggest that enrichment reduces the impact of cocaine–associated environmental stimuli, and hence it may be a useful intervention for attenuating cue–elicited craving in humans.
Related Articles
Environmental Envoys from 19 countries visit Bayer: Project part of partnership between the United Nations Environment Programme and Bayer
BayNews International, 11/11/09
Relevance Score: 91%
Home Environmental Health Risks of People With Developmental Disabilities Living in Community-Based Residential Settings: Implications for Community-Health Nurses
Journal of Community Health Nursing, 11/09/09
Relevance Score: 87%
Improving work environments in health care: Test of a theoretical framework
Health Care Management Review, 11/04/09
Relevance Score: 87%
Perceptions of Environmental and Occupational Health Hazards Among Agricultural Workers in Washington State
AAOHN Journal, 10/28/09
Relevance Score: 87%
Routine Work Environment Stress and PTSD Symptoms in Police Officers
The Journal of Nervous and Mental Disease, 10/21/09
Relevance Score: 87%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: Implications for early diagnosis and treatment
Archives of Gerontology and Geriatrics, 12/01/09
Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability
Amyotrophic Lateral Sclerosis, 11/30/09
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Amyotrophic Lateral Sclerosis, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


